Sorry, you need to enable JavaScript to visit this website.

A Study to Understand the Effect of a Study Medicine Called ARV-471 on Dabigatran Etexilate in Healthy Adults

An Interventional, Phase 1, Open-Label, Fixed-Sequence, 2-Period Study to Evaluate the Effect of a Single Oral Dose of ARV-471 (PF-07850327) on the Pharmacokinetics of Dabigatran in Healthy Participants

Category & Conditions: Cancer
Medicine: VEPDEGESTRANT
ClinicalTrials.gov Identifier (NCT): NCT05673889
Protocol ID: C4891008
PrintDownload
Open Plain Language Summary Result: Click here